🌐

Units

Region & currency

🌐

Appearance

Research-use-only catalog

Peptides

A retail-scaffold catalog of peptides for eventual research-use-only sale. This is not a live store: nothing here is for sale, and no item can be added to the cart.

Learn about peptides

Research use only β€” not for sale

Peptides are research compounds; most are not approved for human use and are not dietary supplements or medicines. Availability and legality differ by country. Listing here is a scaffold only. Before any real sale, a legal sign-off plus a licensed / eligibility + age + jurisdiction gate is required.

Eligibility + legal review required before purchase

No checkout exists for these items. Enabling any sale would require, at minimum: documented legal sign-off per market, a licensed-purchaser / eligibility check, and an age + jurisdiction gate β€” none of which is in place today.

Legality & safe sourcing in 🌐 United States

Legal status

Mixed. FDA-approved peptide drugs (semaglutide as Ozempic/Wegovy/Rybelsus, tirzepatide as Mounjaro/Zepbound) are prescription-only and the only fully legal route. Licensed-compounded peptides (503A patient-specific / 503B outsourcing facilities) are legal only for substances on the FDA 503A/503B bulks lists or with a valid clinical-need exception; mass compounding of GLP-1 copies is no longer permitted now that the shortages have ended. BPC-157, TB-500, ipamorelin, CJC-1295, thymosin and most 'wellness' peptides are NOT FDA-approved and are largely unavailable through legitimate compounding; they are sold only as research-use-only chemicals (not for human use).

The only legitimate route

Approved-drug-only for the GLP-1s: obtain branded Ozempic/Wegovy/Zepbound/Mounjaro via a licensed prescriber or a legitimate telehealth platform that prescribes FDA-approved brand product. Compounded peptides only from a state-licensed 503A pharmacy or FDA-registered 503B outsourcing facility against a valid prescription where a documented clinical need/bulks-list eligibility exists. Non-approved peptides (BPC-157 etc.) have no legitimate consumer route for human use.

Shortages ended (tirzepatide Dec 2024, semaglutide Feb 2025), triggering wind-down of mass GLP-1 compounding. On 30 Apr 2026 FDA proposed excluding semaglutide/tirzepatide/liraglutide from the 503B bulks list (comment period to 30 Jun 2026). BPC-157 was removed from 503A Category 2 effective 22 Apr 2026 and is under PCAC review (meeting 23-24 Jul 2026); removal from Category 2 is NOT authorization to compound. FDA/HHS have taken action against telehealth advertising of compounded GLP-1s. Verify prescriber license and that telehealth dispenses brand-name approved product.

Switch your region in the header to see another market. We do not link to or endorse any gray-market or β€œresearch-chemical” seller β€” only approved drugs on prescription and licensed pharmacies.

How to verify a peptide is legitimate & lab-tested

  • Independent third-party Certificate of Analysis (COA) for the specific batch/lotA batch-specific COA from an outside lab confirms what is actually in the vial. In-house-only testing is a conflict of interest because the seller both profits from and certifies the product. The COA should match the exact lot number on your product.
  • Testing lab is ISO/IEC 17025 accredited (verifiable on ANAB or A2LA registries)ISO 17025 accreditation means the lab is independently qualified to produce reliable analytical results. You can cross-check the lab's name on the ANAB (ANSI National Accreditation Board) or A2LA registry, so a named, verifiable accredited lab is far more trustworthy than an unnamed one.
  • Identity and purity testing by HPLC plus mass spectrometry, with purity (typically >98%) and correct molecular weight documentedHPLC quantifies purity and the chromatogram reveals impurities; mass spectrometry confirms the molecule is actually the labeled peptide and not a substitute or degraded product. Both together verify identity and quality, not just presence.
  • Potency within label tolerance (about +/-10%) and a COA dated recently (e.g., within ~90 days)Confirms the dose is accurate and the data is current rather than a stale or recycled certificate. Out-of-tolerance potency means under- or over-dosing risk.
  • USP / cGMP compounding with documented sterility (USP <71>) and endotoxin (USP <85> LAL) testing for any injectableInjectable products must be sterile and endotoxin-controlled to avoid infection and pyrogenic reactions; cGMP and USP-standard testing (sterility, endotoxin, pH, appearance) are the baseline safety controls a legitimate compounder documents.
  • Verifiable licensed-pharmacy credentials: state-licensed 503A pharmacy or FDA-registered 503B outsourcing facility (or the local equivalent national-regulator registration)A legitimate compounded product comes only from a properly licensed/registered facility against a valid prescription. 503B facilities operate under full cGMP; in the UK check GPhC registration, in the EU check the national register and the EU common online-pharmacy logo, in Canada provincial licensing and a DIN. Unlicensed sellers cannot legally supply human-use product.
  • Batch/lot identity traceability: lot number on the product matches the COA and the pharmacy/manufacturer can trace itLot traceability lets you tie the physical product to its specific test data and enables recalls. If the lot on the vial does not match the COA, the certificate does not actually describe what you received.
  • Product is an approved drug (or legitimately prescribed) rather than labeled 'research use only / not for human consumption'RUO labeling is the hallmark of the gray/research-chemical market and signals the product was never made, tested, or authorized for human use. The only legitimate consumer routes are approved drugs dispensed on prescription or pharmacy-compounded products where lawful.

Covers 8 markets: US Β· CA Β· UK Β· EU Β· AU Β· NZ Β· AE Β· LB. A legitimate product is an approved drug dispensed on prescription, or one compounded by a licensed pharmacy where lawful β€” with a batch-specific COA from an ISO 17025 lab.

Not a lawful supplement Β· research use only

Cosmetic-grade topical versions of this peptide are sold in our skincare, haircare, or dental lines β€” this research-use-only listing is separate.

US:
Restricted in US
CA:
Restricted in CA
View details
AOD-9604Peptide
Not approved Β· research use only
US:
Not available in US
CA:
Not available in CA
View details
Not a lawful supplement Β· research use only

Cosmetic-grade topical versions of this peptide are sold in our skincare, haircare, or dental lines β€” this research-use-only listing is separate.

US:
Restricted in US
CA:
Restricted in CA
View details
BPC-157Peptide
Not approved Β· research use only
US:
Not available in US
CA:
Not available in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Cosmetic-grade topical

Cosmetic-grade topical versions of this peptide are sold in our skincare, haircare, or dental lines β€” this research-use-only listing is separate.

US:
See regulatory notes
CA:
See regulatory notes
View details
CJC-1295Peptide
Prescription drug Β· not sold here
US:
Restricted in US
CA:
Prescription in CA
View details
Prescription drug Β· not sold here
US:
Restricted in US
CA:
Prescription in CA
View details
Not approved Β· research use only
US:
Not available in US
CA:
Prescription in CA
View details
Cosmetic-grade topical

Cosmetic-grade topical versions of this peptide are sold in our skincare, haircare, or dental lines β€” this research-use-only listing is separate.

US:
See regulatory notes
CA:
See regulatory notes
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Not approved Β· research use only
US:
Not available in US
CA:
Not available in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
IGF-1 LR3Peptide
Not approved Β· research use only
US:
Not available in US
CA:
Not available in CA
View details
IpamorelinPeptide
Prescription drug Β· not sold here
US:
Restricted in US
CA:
Prescription in CA
View details
Not approved Β· research use only
US:
Not available in US
CA:
Prescription in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Not approved Β· research use only

Cosmetic-grade topical versions of this peptide are sold in our skincare, haircare, or dental lines β€” this research-use-only listing is separate.

US:
Not available in US
CA:
Not available in CA
View details
MOTS-cPeptide
Prescription drug Β· not sold here
US:
Restricted in US
CA:
Prescription in CA
View details
Not a lawful supplement Β· research use only

Cosmetic-grade topical versions of this peptide are sold in our skincare, haircare, or dental lines β€” this research-use-only listing is separate.

US:
Restricted in US
CA:
Restricted in CA
View details
Not approved Β· research use only
US:
Not available in US
CA:
Not available in CA
View details
SelankPeptide
Prescription drug Β· not sold here
US:
Restricted in US
CA:
Prescription in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
SemaxPeptide
Prescription drug Β· not sold here
US:
Restricted in US
CA:
Prescription in CA
View details
SermorelinPeptide
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details
Not approved Β· research use only
US:
Not available in US
CA:
Not available in CA
View details
Prescription drug Β· not sold here
US:
Prescription in US
CA:
Prescription in CA
View details

Legality labels above are read from XyberHealth’s per-ingredient regulatory data and the per-market peptide regulation reference β€” not invented. This page is a scaffold and not an offer to sell.